Dear Editor, We read with interest the article by Mehta et al. regarding stomatocytosis as a heralding sign of acute Wilsonian crisis [1] . Stomatocyte formation is frequently observed in liver disease irrespective of the underlying etiology and has been attributed to an increase of lysolecithin in the inner layer of the red cell membrane. The degree of stomatocytosis is analogous to the severity of liver disease [2] . Stomatocytosis per se is not characteristic of Wilson's disease, but as the authors indicate, evidence of liver dysfunction in a young patient should raise suspicions for the disease. However, it is important to note that Wilson's disease can cause both acute hemolytic anemia with no or non-specific morphologic abnormalities and a distinctive hemolytic crisis with the characteristic features of oxidant-induced erythrocyte damage [2] . In our letter, we comment on an adolescent who manifested brisk oxidative hemolysis as the presenting symptom of Wilson's disease.
A 17-year-old girl, previously in good health, was admitted with a 5-day history of weakness and jaundice. The patient denied any exposure to drugs or chemicals and there was no family history of anemia or jaundice. On examination, she was alert, temperature was 37.5°C and the liver span enlarged at 15 cm. Spleen was not palpable and no neurological abnormalities were detected. The hemoglobin level was 6.7 g/dL, mean corpuscular volume 100 fL, the leucocyte count 22,000/μL, and platelets 186,000/μL. Serum level of total bilirubin was 37 mg/dL (conjugated bilirubin 22 mg/dL), ALT 25 U/L, AST 133 U/L, LDH 550 U/L and alkaline phosphatase 10 U/L. Serum creatinine level was normal and the prothrombin time ratio was prolonged at 1.6. The reticulocyte count was 12% and serum haptoglobulin <7 mg/dL. The blood film showed polychromasia, basophilic stippling, many irregularly contracted cells and occasional blister cells (Fig. 1) . A Heinz body preparation with methyl violet at 1-h incubation was positive, confirming thus the oxidative nature of hemolysis. Coomb's test and screening for hemoglobin instability and G6PD deficiency gave negative results. Wilson's disease was suspected because of the patient's liver dysfunction and oxidant-induced hemolysis in the absence of any drug intake; this was confirmed by the detection of Kayser-Fleischer rings on slit-lamp examination and the copper studies: ceruloplasmin 4.7 mg/dL (normal 22-61 mg/dL), serum copper level 362 μg/dL (normal 78-131 μg/dL). The patient was stabilized with transfusions and chelation therapy and she was referred for evaluation to a liver transplantation center.
Erythrocyte damage in Wilson's disease is believed to be caused directly by the oxidant effects of copper. Central to the pathophysiology is the impaired biliary excretion, due to the mutated transporter protein ATP7B, and accumulation of copper within the hepatocytes [3] . Unbound inorganic copper spills out of the damaged liver into the bloodstream and interacts with the erythrocytes generating free oxygen radicals and hydrogen peroxides via the Fenton's reaction [3] [4] [5] . Various lines of evidence suggest that high levels of free serum copper have a direct effect on either oxidation of hemoglobin, direct damage to the membrane phospholipids, or inhibition of glycolytic enzymes [6] . The oxidative damage of the membrane accounts for the irregularly contracted cells and the precipitation of denaturated hemoglobin for the Heinz bodies. The subsequent destruction of the red cells occurs both intravascularly and extravascularly.
As mentioned above, Wilson's disease can cause both acute hemolytic anemia with no specific morphologic abnormality and an acute Heinz body hemolytic anemia. However, the mechanism of red cell destruction is the same in both instances and subsequent on the copper-mediated oxidation of erythrocytic components. Factors that may account for the morphologic differences include the speed and amplitude of copper flux, the rate of splenic clearance and the diverse effects of the metal in many parts of the erythrocyte. The shape changes commonly observed in hepatic disease, such as the stomatocytosis reported by Mehta et al., may contribute to the hemolysis by enhancing extravascular destruction.
The hemolytic crisis may rarely be the initial manifestation of Wilson's disease and antedate symptomatic liver or neurologic disease by months. The presence of oxidantinduced hemolysis in a young patient in the absence of G6PD deficiency, unstable hemoglobin, or a history of drug or chemical exposure should be indicative of Wilson's disease.
